Vidutolimod
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Vidutolimod, covering 2025-09-19 to 2026-07-02. Get the full timeline:
Most recent: Clinical Trial Results: Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab [Phase 2]